Recent literature has reported that CDC20 is highly expressed in pancreatic cancer [27], colon cancer [28], osteosarcoma cancer [29], lung adenocarcinoma [30], oral squamous cell carcinoma, and hepatocellular carcinoma [31, 32]. This evidence concerns the gene CDC20 and hepatocellular carcinoma.